loading

Finanzdaten der Coherus Oncology Inc-Aktie (CHRS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
34.94%
10.25
7.599 54.14 70.77 64.98
Cost Of Revenue
27.97%
3.395
2.653 33.86 20.74 28.37
Gross Profit
38.68%
6.859
4.946 20.29 50.03 36.61
Operating Expenses
3.90%
52.34
50.38 62.53 56.42 57.12
Interest Income/Expense
5.91%
2.277
2.15 5.346 5.362 5.334
Benefits Costs and Expenses
0.22%
55.12
55.00 104.84 81.53 77.90
Costs And Expenses
5.10%
55.74
53.03 96.39 77.16 85.49
Depreciation and Amortization
2.87%
1.016
1.046 1.033 1.549 1.187
Operating Income/Loss
0.11%
-45.49
-45.44 -42.25 -6.387 -20.51
Income/Loss From Continuing Operations Before Tax
5.35%
-44.86
-47.40 -50.70 -10.75 -12.92
Income/Loss From Continuing Operations After Tax
5.35%
-44.86
-47.40 -50.70 -10.75 -12.92
Income/Loss From Discontinued Operations, Net Of Tax
3,836%
342.63
-9.171 - - -
Net Income/Loss
626.38%
297.77
-56.57 -50.70 -10.75 -12.92
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.19%
116.08
115.86 0.2903 115.21 114.82
Diluted Average Shares
0.19%
116.08
115.86 -11.73 115.21 114.82
Basic Earnings Per Share
624.49%
2.57
-0.49 -0.44 -0.09 -0.11
Diluted Earnings Per Share
624.49%
2.57
-0.49 -0.40 -0.09 -0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):